Skip to main content
IMUGENE LIMITED logo

IMUGENE LIMITED — Investor Relations & Filings

Ticker · IMU ISIN · AU000000IMU9 LEI · 984500A5C9KF08EAF248 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,442 across all filing types
Latest filing 2021-10-14 Capital/Financing Update
Country AU Australia
Listing ASX IMU

About IMUGENE LIMITED

https://imugene.com

Imugene Limited is a clinical-stage immuno-oncology company focused on developing immunotherapies to activate the immune system against various cancers. The company’s pipeline features multiple platform technologies, including B-cell activating immunotherapies, oncolytic viruses, and CAR-T cell enhancement therapies. Key clinical candidates include HER-Vaxx, targeting HER2-positive gastric cancer, and PD1-Vaxx, a checkpoint inhibitor immunotherapy. Imugene is also advancing the CF33 oncolytic virus platform, which includes VAXINIA and CHECKvacc, alongside the onCARlytics program. The onCARlytics platform is designed to enable CAR-T cells to target solid tumors by inducing the expression of CD19 on cancer cell surfaces. These programs aim to address unmet needs in oncology by providing targeted, potent, and potentially less toxic alternatives to conventional treatments.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - IMU 9 pages 32.3KB
Capital/Financing Update Classification · 95% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary fully paid shares. It includes specifics about the number of securities, issue dates, and classifications of securities to be quoted. There is no financial performance data, earnings information, or management discussion. The document is a regulatory announcement related to capital market activities, specifically the quotation of securities following option exercises. This fits the category of Capital/Financing Update (CAP) as it concerns changes in the company's capital structure and securities quotation on the exchange.
2021-10-14 English
Notice of Annual General Meeting/Proxy Form 14 pages 975.1KB
AGM Information Classification · 100% confidence The document is titled 'Notice of Annual General Meeting' and includes detailed information about the AGM such as date, time, location (online), agenda items including financial statements and reports, resolutions to be voted on (e.g., remuneration report, re-election of director, ratification of equity issuance), voting exclusion statements, and explanatory memorandum. It does not contain the actual financial statements or reports but rather the notice and information for shareholders to attend and vote at the AGM. The document length is about 15,000 characters, which is consistent with a detailed notice and explanatory memorandum but not a full annual report or financial report. The presence of proxy forms and voting instructions further supports this classification. Therefore, this document is best classified as AGM Information (AGM-R).
2021-10-13 English
Change of Director's Interest Notice - LR 2 pages 240.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including shares and options, with specifics on dates, number of securities held before and after the change, and nature of the change (e.g., on-market trade). The document is a formal notification of insider share transactions by a company director. It does not contain financial statements, earnings data, or management discussion. The content matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is under 5,000 characters and is not an announcement of a report publication but the actual notice of director's interest change. Therefore, the correct classification is DIRS.
2021-10-10 English
Application for quotation of securities - IMU 9 pages 32.3KB
Share Issue/Capital Change Classification · 95% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary fully paid shares. It includes specifics about the number of securities, issue dates, prices, and the resulting capital structure. There is no financial performance data, management discussion, or regulatory certification. The content focuses on the issuance and quotation of new shares following option exercises, which aligns with announcements about share capital changes rather than financial reports or other categories. Therefore, the document fits best under the category of Share Issue/Capital Change (SHA). The document length (8405 characters) and detailed issuance information support this classification with high confidence.
2021-10-07 English
Investor Presentation 31 pages 5.1MB
Investor Presentation Classification · 95% confidence The document is a detailed presentation from Imugene Limited dated October 2021. It includes extensive information about the company's technology platforms, clinical trials, leadership team, investment highlights, and scientific data. The content is structured as a presentation with slides, disclaimers, and detailed descriptions of clinical programs and results. There is no indication that this is a regulatory filing, audit report, earnings release, or any other formal report type. Instead, it matches the characteristics of an Investor Presentation (IP), which typically provides detailed financial, strategic, and scientific information to investors. The length (15,000 characters) and depth of content support this classification. Therefore, the document is best classified as an Investor Presentation (IP).
2021-10-04 English
Annual Report to shareholders 97 pages 9.3MB
Regulatory Filings
2021-10-03 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.